Evidence map›Paper›PMID 15774883›Full record

ArticleJournal of bacteriology2005

MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus.

Q C Truong-Bolduc, P M Dunman, J Strahilevitz, S J Projan, D C Hooper

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 290 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Genetic and Phenotypic Characteristics of FiveAnimals : an open access journal from MDPI · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. First fatal human bloodstream infection caused byFrontiers in cellular and infection microbiology · 2026
    Article
  11. Staphylococcus aureus in commercial laying hens from Pernambuco, Brazil: detection of efflux pumps and β-lactam resistance genes.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  12. Article
  13. Evaluation of the Activity of Amino Chalcone AgainstPharmaceuticals (Basel, Switzerland) · 2025
    Article
  14. Article
  15. NorA and Tet38 efflux pumps enableAntimicrobial agents and chemotherapy · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. A small regulatory RNA controls antibiotic adaptation inAntimicrobial agents and chemotherapy · 2025
    Article
  20. Review

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Q C Truong-BolducDivision of Infectious Diseases, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114-2696, USA.
P M Dunman
J Strahilevitz
S J Projan
D C Hooper
Massachusetts General Hospital · USHarvard University · US

Funding

QUINOLONE RESISTANCE MECHANISMS IN STAPHYLOCOCCUS AUREUSR01AI023988 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HOOPER, DAVID C · 1986 to 2007
$3.0M
NIAID NIH HHS R01 AI023988NIAID NIH HHS R01 AI23988
6 · The paper itself

Abstract

In an analysis of the resistance mechanisms of an mgrA mutant, we identified two genes encoding previously undescribed transporters, NorB and Tet38. norB was 1,392 bp and encoded a predicted 49-kDa protein. When overexpressed, NorB led to an increase in resistance to hydrophilic quinolones, ethidium bromide, and cetrimide and also to sparfloxacin, moxifloxacin, and tetracycline, a resistance phenotype of the mgrA mutant. NorA and NorB shared 30% similarity, and NorB shared 30 and 41% similarities with the Bmr and Blt transporters of Bacillus subtilis, respectively. The second efflux pump was a more selective transporter that we have called Tet38, which had 46% similarity with the plasmid-encoded TetK efflux transporter of S. aureus. tet38 was 1,353 bp and encoded a predicted 49-kDa protein. Overexpression of tet38 produced resistance to tetracycline but not to minocycline and other drugs. norB and tet38 transcription was negatively regulated by MgrA. Limited binding of MgrA to the promoter regions of norB and tet38 was demonstrated by gel shift assays, suggesting that MgrA was an indirect regulator of norB and tet38 expression. The mgrA norB double mutant was reproducibly twofold more susceptible to the tested quinolones than the mgrA mutant. The mgrA tet38 double mutant became more susceptible to tetracycline than the wild-type parent strain. These data demonstrate that overexpression of NorB and Tet38 contribute, respectively, to the hydrophobic quinolone resistance and the tetracycline resistance of the mgrA mutant and that MgrA regulates expression of norB and tet38 in addition to its role in regulation of norA expression.

Indexed as

Amino Acid SequenceAnti-Infective AgentsBacterial ProteinsBiological Transport, ActiveDrug Resistance, BacterialFluoroquinolonesMembrane Transport ProteinsMolecular Sequence DataPhylogenyRepressor ProteinsSequence AlignmentStaphylococcus aureusSubstrate SpecificityTetracyclinesAnti-Infective AgentsBacterial ProteinsFluoroquinolonesMembrane Transport ProteinsRepressor ProteinsTetracyclines

Identifiers

PMID15774883
PMCPMC1065235
OpenAlexW2111488365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.